New results on the oral Alzheimer's pill, valiltramiprosate, claims it can slow down the brain atrophy that causes ...
A research team led by Prof. HOU Xingliang from the South China Botanical Garden of the Chinese Academy of Sciences has used genome-wide association ...
Ultragenyx Pharmaceutical has dosed the first participant in Aurora, a study evaluating GTX-102 (apazunersen) for angelman ...
Research from UChicago dissects how a single genetic switch helps butterflies mimic wing patterns of other species to protect ...
News Medical on MSN
Proimmune Ltd introduces Prove® SL Self-Loading MHC Class I Monomers to improve T cell research flexibility
ProImmune Ltd, a global leader in life science reagents and services, today announced the launch of its new ProVE® SL Self-Loading MHC Class I Monomers.
Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE) today announced that the first patient has been dosed in the Aurora study (NCT07157254) evaluating the efficacy and safety of GTX-102 (apazunersen), an ...
AI-powered vector design and preclinical validation mark the first step in a multi-phase program aimed at accelerating the path from discovery to clinical assessment in Alzheimer's disease.
Current smoking was the most important predictor for a detrimental effect of aspirin on cancer incidence, whereas CHIP was the most important predictor for a beneficial effect of aspirin,” researchers ...
This insightful review explores key areas of cancer genetic research, focusing on genes that may benefit from ...
Coya Therapeutics, Inc. (NASDAQ: COYA) ("Coya" or the "Company"), a clinical-stage biotechnology company focused on ...
The Fast-Twitch Gene You Didn't Know You Had Your DNA might be giving you an edge or could be holding you back. The ACTN3 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results